Search Results - Guangxi Sun
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents by Jinge Zhao, Junru Chen, Guangxi Sun, Pengfei Shen, Hao Zeng
Published in Cancer Biology & Medicine (2024-11-01)Get full text
Article -
6
-
7
-
8
The prognostic value of sarcopenia in acute-on-chronic liver failure: a systematic review and meta-analysis by Sike He, Chang-Hai Liu, Yuan Wang, Ziqi Li, Zhenhua Liu, Hao Zeng, Guangxi Sun
Published in BMC Gastroenterology (2025-04-01)Get full text
Article -
9
-
10
Exploring the clinical and diagnostic value of metagenomic next-generation sequencing for urinary tract infection: a systematic review and meta-analysis by Sike He, Haolin Liu, Xu Hu, Jinge Zhao, Jiayu Liang, Xingming Zhang, Junru Chen, Hao Zeng, Guangxi Sun
Published in BMC Infectious Diseases (2024-09-01)Get full text
Article -
11
Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A Systematic Review and Bay... by Junru Chen, Yuchao Ni, Guangxi Sun, Banghua Liao, Xingming Zhang, Jinge Zhao, Sha Zhu, Zhipeng Wang, Pengfei Shen, Hao Zeng
Published in Frontiers in Oncology (2020-09-01)Get full text
Article -
12
Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma by Yanxiang Shao, Sanchao Xiong, Guangxi Sun, Weichao Dou, Xu Hu, Weixiao Yang, Thongher Lia, Shi Deng, Qiang Wei, Hao Zeng, Xiang Li
Published in Cancer Medicine (2020-02-01)Get full text
Article -
13
First-line systemic therapy in patients with metastatic or locally advanced urothelial carcinoma: a systematic review and network meta-analysis of randomized controlled trials by Yandong Xie, Haoyang Liu, Yanfeng Tang, Yaowen Zhang, Nanwei Xu, Fengnian Zhao, Jinge Zhao, Guangxi Sun, Zhenhua Liu, Pengfei Shen, Hao Zeng, Junru Chen
Published in Therapeutic Advances in Medical Oncology (2025-07-01)Get full text
Article -
14
Tertiary lymphoid structures potentially promote immune checkpoint inhibitor response in SMARCB1-deficient medullary renal cell carcinoma by Yanfeng Tang, Junru Chen, Mengxin Zhang, Xu Hu, Jingjing Guo, Yaowen Zhang, Yuntian Chen, Haoyang Liu, Junjie Zhao, Ni Chen, Guangxi Sun, Hao Zeng
Published in npj Precision Oncology (2024-11-01)Get full text
Article -
15
The mutational pattern of homologous recombination repair genes in urothelial carcinoma and its correlation with immunotherapeutic response by Junru Chen, Yanfeng Tang, Huanhuan Liu, Guangxi Sun, Haoyang Liu, Junjie Zhao, Zilin Wang, Yanrui Zhang, Feng Lou, Shanbo Cao, Jiayue Qin, Huina Wang, Banghua Liao, Hao Zeng
Published in Cancer Medicine (2023-12-01)Get full text
Article -
16
Therapeutic Potential of Human Adipose-Derived Stem Cell Exosomes in Stress Urinary Incontinence – An in Vitro and in Vivo Study by Jianshu Ni, Hongchao Li, Yiwen Zhou, Baojun Gu, Yuemin Xu, Qiang Fu, Xufeng Peng, Nailong Cao, Qingchun Fu, Meng Jin, Guangxi Sun, Jihong Wang, Yinpeng Jin, Feng Liu
Published in Cellular Physiology and Biochemistry (2018-08-01)Get full text
Article -
17
Exosomal TUBB3 mRNA expression of metastatic castration‐resistant prostate cancer patients: Association with patient outcome under abiraterone by Sha Zhu, Yuchao Ni, Guangxi Sun, Zilin Wang, Junru Chen, Xingming Zhang, Jinge Zhao, Xudong Zhu, Jindong Dai, Zhenhua Liu, Jiayu Liang, Haoran Zhang, Yaowen Zhang, Pengfei Shen, Hao Zeng
Published in Cancer Medicine (2021-09-01)Get full text
Article -
18
The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer by Jinge Zhao, Guangxi Sun, Fengnian Zhao, Junru Chen, Sha Zhu, Nanwei Xu, Haoyang Liu, Jiayu Liang, Xu Hu, Xingming Zhang, Yuchao Ni, Jindong Dai, Zhipeng Wang, Pengfei Shen, Zhenhua Liu, Ni Chen, Jiyan Liu, Hao Zeng
Published in Asian Journal of Surgery (2023-10-01)Get full text
Article -
19
Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinom... by Junjie Zhao, Xiuyi Pan, Zilin Wang, Yuntian Chen, Dingbang Liu, Yu Shen, Xinyuan Wei, Chenhao Xu, Xingming Zhang, Xu Hu, Junru Chen, Jinge Zhao, Bo Tang, Guangxi Sun, Pengfei Shen, Zhenhua Liu, Hao Zeng, Jiayu Liang
Published in European Journal of Medical Research (2024-07-01)Get full text
Article -
20
The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors by Haoran Zhang MD, Xingming Zhang PhD, Xudong Zhu MD, Yuchao Ni MD, Jindong Dai MD, Sha Zhu MD, Guangxi Sun PhD, Zhipeng Wang MD, Junru Chen PhD, Jinge Zhao PhD, Hao Zeng PhD, Zi Li PhD, Pengfei Shen PhD
Published in Cancer Control (2020-11-01)Get full text
Article
